• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL OPTIMA PROTECTOR (P20-O); INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL OPTIMA PROTECTOR (P20-O); INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515064
Device Problem Deflation Problem (1149)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/30/2019
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that a bd phaseal optima protector (p20-o) expansion chamber did not deflate.A plug was noticed in the expansion chamber.
 
Event Description
It was reported that a bd phaseal optima protector (p20-o) expansion chamber did not deflate.A plug was noticed in the expansion chamber.
 
Manufacturer Narrative
The information was re-evaluated and the complaint does not meet our mdr reporting criteria.When the expansion chamber does not deflate, this may lead to customer dissatisfaction or a delay in preparation, but it is unlikely to lead to any degree of harm/serious injury.
 
Manufacturer Narrative
H.6.Investigation summary: one picture was received showing some drops through the hydrophobic filter.No samples are available for investigation.Thirty-one (31) retained samples were taken for investigation.Visual inspection reveals no defects.Twenty (25) samples were inflated through the spike using a syringe with 50 ml of air.All of the samples expanded the chamber properly and no defects were found on the film.Functional test was performed on six (6) samples.The injector was connected to a syringe and attached to the protector + vial, following instructions explained in the ifu.In all cases expansion chamber worked properly (inflated and deflated properly).No leak was found through the hydrophobic filter.Inspections and tests: according to ph-322, visual inspection of protector takes place during manufacturing process.(the correct assembly of the components and the absence of foreign matter are verified).According to ph-322 leak test and burst test are performed on the first lot of each month using a z-axis equipment.The volume of the expansion chamber is checked on the first lot of each month according to ph-322/pc-225 as well.The machine has a leak test and flow test, both tests will detect if the sample has the channels 100% blocked in such a way that he chambers can´t be inflated.Flow test will detect the bad sample since the flow rate will be 0 l/min.Leak test will detect the bad samples since the chamber will not be thermoformed and consequently, the leak test will fail or even will not start.The root cause of the defect may be related to defective injectors.A situation analysis (sa# mps-19-1349-sa) was initiated for the injector complaints with further details related to the investigation: ¿it was observed that lubrication in the membrane pocket and cannula may have migrated into the cannula and potentially occluded the flow location.The batches that demonstrated difficulty in aspirating were then evaluated for lubrication consistency.Several batches demonstrated similar gell like appearance and have been placed on a global hold.Remaining batches were not placed on global hold because they didn¿t demonstrate difficulty in aspiration.¿ if protectors were used with defective injectors, occlusion may avoid the properly work of the protector chamber.
 
Event Description
It was reported that a bd phaseal optima protector (p20-o) expansion chamber did not deflate.A plug was noticed in the expansion chamber.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL OPTIMA PROTECTOR (P20-O)
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
MDR Report Key8355706
MDR Text Key140010496
Report Number3003152976-2019-00169
Device Sequence Number1
Product Code ONB
UDI-Device Identifier00382905150647
UDI-Public00382905150647
Combination Product (y/n)N
PMA/PMN Number
K181221
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup,Followup
Report Date 04/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date06/30/2019
Device Catalogue Number515064
Device Lot Number1807701
Date Manufacturer Received01/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-